- Riley Group Research Group
Postdoctoral Research Scientist
Damien Barnette received his bachelor’s degree in Chemistry from University of North Carolina at Chapel Hill, USA. He worked several years in the biotechnology industry before beginning his doctoral studies at University of Miami under the advisement of Associate Professor Joy Lincoln investigating the role of bHLH transcription factor scleraxis in heart valve development and disease. In 2014, he relocated to Oxford, where he continues a career in cardiovascular research as a British Heart Foundation postdoctoral researcher in the laboratory of Professor Paul Riley.
Damien’s current research interests include elucidating the role of inflammation in heart repair and regeneration, and the molecular mechanisms that regulate pro-inflammatory responses after cardiac injury.
RNA-Seq Analysis to Identify Novel Roles of Scleraxis during Embryonic Mouse Heart Valve Remodeling
Barnette DN. et al, (2014), PLoS ONE, 9, e101425 - e101425
Tgfβ-Smad and MAPK signaling mediate scleraxis and proteoglycan expression in heart valves
Barnette DN. et al, (2013), Journal of Molecular and Cellular Cardiology, 65, 137 - 146